Genus plc (GENSF)
OTCMKTS · Delayed Price · Currency is USD
35.15
0.00 (0.00%)
Oct 22, 2025, 8:00 PM EDT
Genus Revenue
In the fiscal year ending June 30, 2025, Genus had annual revenue of 672.80M GBP with 0.60% growth. Genus had revenue of 336.40M in the half year ending June 30, 2025, a decrease of -0.91%.
Revenue
672.80M GBP
Revenue Growth
+0.60%
P/S Ratio
2.44
Revenue / Employee
210.91K GBP
Employees
3,190
Market Cap
2.25B USD
Revenue Chart
* This company reports financials in GBP.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 672.80M | 4.00M | 0.60% |
| Jun 30, 2024 | 668.80M | -20.90M | -3.03% |
| Jun 30, 2023 | 689.70M | 96.30M | 16.23% |
| Jun 30, 2022 | 593.40M | 19.10M | 3.33% |
| Jun 30, 2021 | 574.30M | 22.90M | 4.15% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Jushi Holdings | 256.36M |
| Glass House Brands | 221.55M |
| Elite Pharmaceuticals | 105.45M |
| Silence Therapeutics | 27.17M |
| Nuo Therapeutics | 1.95M |
| Northwest Biotherapeutics | 1.09M |
Genus News
- 3 days ago - Genius Group (GNS) Sponsors CoinDesk's Bitcoin Treasury Month - GuruFocus
- 4 days ago - GNS Sees Increased Investment from CEO Roger Hamilton - GuruFocus
- 4 weeks ago - GNS Reports Decline in 1H Revenue Amid Legal Challenges - GuruFocus
- 4 weeks ago - Genius Group GAAP EPS of -$0.36 misses by $0.28, revenue of $2.72M misses by $1.07M - Seeking Alpha
- 5 weeks ago - Genius Group (GNS) Executes Share Buyback and Reaches Market Cap Milestone - GuruFocus
- 6 weeks ago - Genus PLC (GENSF) Full Year 2025 Earnings Call Highlights: Strong Profit Growth and Strategic ... - GuruFocus
- 6 weeks ago - Full Year 2025 Genus PLC Earnings Call Transcript - GuruFocus
- 7 weeks ago - Genus Plc (GENSY) Q4 2025 Earnings Call Prepared Remarks Transcript - Seeking Alpha